Epinephrine is the first-line treatment for severe allergic reactions, but far too often, people do not use or get it when needed. The FDA’s recent approval of neffy®, an epinephrine nasal spray , is a huge breakthrough. The allergy community now has a treatment option for severe and potentially life-threatening allergic reactions that does not use a needle. “An epinephrine nasal spray like neffy offers a new treatment option for people with anaphylaxis,“ said Kenneth Mendez, President and…
Quelle: Asthma and Allergy Foundation of America
Titelbild/Grafik: Asthma and Allergy Foundation of America (AAFA)
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Quick-Links
Aktuelles von Asthma and Allergy Foundation of America
- What to Do If You Can't Afford Your Asthma Medicines
- August Research Update: Asthma, Chronic Hives, and Hypereosinophilic Syndrome (HES)
- Caring for Children with Atopic Dermatitis (Video Series)
- Brace Yourselves: The Biggest Time for Asthma Attacks Is Coming
- FDA Approves neffy® Epinephrine Nasal Spray for Treating Severe Allergic Reactions
- Ask Congress to Support the Indoor Air Quality and Healthy Schools Act
- July Research Update: Asthma, CSU, and Eczema Treatments
- How Does Rain Affect Pollen Levels?
- Asthma and Heat: Managing Your Symptoms and Risk
- Summer Camp with Asthma and Allergies
